Beinao-1 advances to registered clinical trials with enrollment plans for 2026

NeuCyber NeuroTech / Chinese Institute for Brain Research/Beinao-1

Following successful early investigator-initiated trials, Beinao-1 transitioned to registered clinical trials in March 2026. The roadmap calls for completing 36 human implantations in 2026 and enrolling all registrational clinical trial participants that year, with medical device registration application targeted for 2027.

• Transition from investigator-initiated to formal registered clinical trials
• Target of 36 total implantations in 2026
• Medical device registration application targeted for 2027
• Planned pilot deployment at top-tier hospitals nationwide in 2027